SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950116-01-501199
Filing Date
2001-11-27
Accepted
2001-11-27 00:00:00
Documents
3
Period of Report
2001-07-31

Document Format Files

Seq Description Document Type Size
1 TENKA.TXT tenka.txt 10-K/A 41925
3 EX23-1.TXT ex23-1.txt EX-23 706
4 EX23-2.TXT ex23-2.txt EX-23 824
  Complete submission text file 0000950116-01-501199.txt   45121
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-25169 | Film No.: 1799870
SIC: 2834 Pharmaceutical Preparations